Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon Micro in Pediatric PEI due to Cystic Fibrosis
NCT01747330Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2012
- Primary completion
- Dec 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of pancreatin in pancreatic exocrine insufficiency (EPI), sponsored by Abbott Laboratories. Started Jun 2012; status: completed.
02
Drugs
pancreatin
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT01747330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01747330.